SafeAir designs, develops and manufactures surgical smoke evacuation solutions to reduce staff and patient exposure to hazards associated with surgical smoke.
The transaction is expected to close in the fourth quarter of 2018, subject to customary closing conditions.
“The acquisition of SafeAir AG is highly complementary to the Surgical business of Stryker’s Instruments division and strengthens our smoke evacuation portfolio in both the U.S. and Europe,” said Timothy J. Scannell, MedSurg and Neurotechnology group president.
More articles on devices:
Stryker, NuVasive, Medtronic & more: 11 device company notes
Stryker ‘not in discussions’ to acquire Boston Scientific according to regulatory filing: 5 key points
Stryker hunts tax cut for $92M expansion plans: 5 things to know
